Trial · NCT07899411
Evaluation of the Effect of Mental Imagery Training Combined With Modified Constraint-Induced Movement Therapy in Individuals With Multiple Sclerosis
NCT07899411, Not applicable, Not yet recruiting, Hacettepe University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evaluation of the Effect of Mental Imagery Training Combined With Modified Constraint-Induced Movement Therapy in Individuals With Multiple Sclerosis. Trials, record NCT07899411. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899411
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evaluation of the Effect of Mental Imagery Training Combined With Modified Constraint-Induced Movement Therapy in Individuals With Multiple Sclerosis
- NCT number
- NCT07899411
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 14 participants, estimated
- Lead sponsor
- Hacettepe University
- Conditions
- Multiple Sclerosis
- Interventions
- odified Constraint-Induced Movement Therapy + Mental Imagery Training, Modified Constraint-Induced Movement Therapy
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Wolf Motor Fonksiyon Testi (WMFT) | At baseline, immediately after the 3-week intervention, and at 1-month follow-up. | Assessment of upper extremity motor function using the Wolf Motor Function Test (WMFT). The Functional Ability Scale (FAS) of the Wolf Motor Function Test (WMFT) assesses upper extremity functional performance during 15 tasks. Each task is scored on a 6-point scale ranging from 0 to 5, where 0 indicates that the affected upper extremity was not used during the task and 5 indicates normal movement. Higher scores indicate better functional ability. |
| Secondary | Nine-Hole Peg Test (9HPT) | At baseline, immediately after the 3-week intervention | Assessment of fine manual dexterity and upper extremity function. The Nine-Hole Peg Test (9HPT) assesses manual dexterity. The participant is instructed to place nine pegs into nine holes and remove them as quickly as possible. The time required to complete the task is recorded in seconds. Shorter completion times indicate better manual dexterity and upper extremity function. A completion time of less than 18 seconds indicates good fine motor dexterity. |
| Secondary | Lafayette Hand Grip Test | At baseline, immediately after the 3-week intervention | Assessment of hand grip strength. The assessment will be performed with the participant in a seated position, with the shoulder adducted, the elbow flexed to 90 degrees and positioned close to the trunk, and the forearm and wrist in a neutral position. |
| Secondary | Nelson Visual Hand Reaction Time Test (NVHRT) | At baseline, immediately after the 3-week intervention | Assessment of visual hand reaction time. Participants will be seated with their forearms and hands resting on a table. The thumb and index finger will be positioned 8-10 cm above the table, with their upper surfaces parallel to each other. Participants will be instructed to focus on the midpoint of a ruler held between the thumb and index finger. When the ruler is released, the numerical value corresponding to the point at which the participant catches it will be recorded. Reaction time will be calculated using the formula: Reaction time (s) = √(2 × distance (cm) / 980 cm/s²), where distance represents the distance the ruler falls before being caught and 980 cm/s² is the acceleration due to gravity. The test will be repeated three times, and the mean reaction time will be calculated. |
| Secondary | Modified Fatigue Impact Scale (MFIS) | At baseline, immediately after the 3-week intervention, and at 1-month follow-up. | Assessment of the impact of fatigue on daily functioning. The Modified Fatigue Impact Scale (MFIS) consists of 21 items divided into three subscales: physical (9 items), cognitive (10 items), and psychosocial (2 items). The total score ranges from 0 to 84, with higher scores indicating a greater impact of fatigue on daily functioning and a worse outcome. |
| Secondary | Functional Independence Measure (FIM) | At baseline, immediately after the 3-week intervention, and at 1-month follow-up. | Assessment of functional independence. The Functional Independence Measure (FIM) is an 18-item scale designed to assess an individual's level of independence in basic activities of daily living, including physical and cognitive activities. The scale consists of two domains: the motor domain, comprising self-care (6 items), sphincter control (2 items), transfers/mobility (3 items), and locomotion (2 items); and the cognitive domain, comprising communication (2 items) and social cognition (3 items). Each item is scored on a 7-point scale ranging from 1 to 7, with higher scores indicating greater independence and a better functional outcome. The total score ranges from 18 to 126. |
| Secondary | Motor Activity Log-28 (MAL-28) | At baseline, immediately after the 3-week intervention, and at 1-month follow-up. | Assessment of the amount and quality of use of the affected upper extremity in daily activities. The Motor Activity Log-28 (MAL-28) is a questionnaire used to assess the use of the more affected upper extremity in individuals following stroke. It consists of two subscales: the Amount of Use (AOU) scale, which assesses how frequently the more affected upper extremity is used in daily activities, and the Quality of Movement (QOM) scale, which assesses the quality of movement during these activities. Both subscales use a 6-point rating scale ranging from 0 to 5. Higher scores indicate greater use of the more affected upper extremity and better movement quality. The 28-item version has demonstrated validity and reliability. |
| Secondary | Treatment Satisfaction Measured Using the Visual Analogue Scale (VAS) | Immediately after the 3-week intervention. | Treatment satisfaction will be assessed using a Visual Analogue Scale (VAS) immediately after completion of the 3-week intervention. Participants will rate their overall satisfaction with the intervention on a scale ranging from 0 to 10, where 0 indicates no satisfaction and 10 indicates the highest possible satisfaction. Higher scores indicate greater satisfaction with the intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899411
GET https://conductscience.org/api/trials/v1/NCT07899411/registered